Pee instead of swab: new study tests urine HPV test for cervical cancer

NCT ID NCT06254846

Recruiting now Diagnosis Sponsor: Centre Hospitalier Universitaire de Saint Etienne Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether a simple urine sample can be used instead of a cervical swab to screen for HPV, the virus that causes most cervical cancers. The researchers will collect first-void urine from 350 women aged 30–65 using a special device and compare the results to the standard swab test. They will also ask participants how acceptable they found the urine collection method.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: First-void urine sample collected with Colli-Pee® device
What this could lead to: If successful, this could offer a simple, painless urine test for HPV, making cervical cancer screening more accessible and comfortable.
What could go wrong: This is a single-center study with 350 participants. Previous urine tests have shown lower sensitivity, and this study is still recruiting, so results are not yet confirmed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UTERINE CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical carcinoma Uterine Cervical Neoplasms cervical cancer prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

UTERINE CERVICAL CANCER

Contacts and locations

Locations

Service de Gynécologie Obstétrique - CHU Saint-Etienne
RECRUITING

Saint-Etienne, 42055, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.